Huntington's Disease Clinical Trials Corner: August 2023

J Huntingtons Dis. 2023;12(2):169-185. doi: 10.3233/JHD-239001.

Abstract

In this edition of the Huntington's Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinical trials in Huntington's disease.

Keywords: Huntington disease; clinical trials.

MeSH terms

  • Humans
  • Huntington Disease* / therapy
  • Longitudinal Studies
  • Oligonucleotides

Substances

  • Oligonucleotides